Radar Therapeutics
17 employees on LinkedIn · 1 known investors
Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.
Investors · 1
Founder mafia
2 people who came through Radar Therapeutics went on to found or lead other companies.
Frequently asked questions
- What does Radar Therapeutics do?
- Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.
- Who are Radar Therapeutics's investors?
- Radar Therapeutics's investors include NFX.